CVS Health Reports Q4 Beat but Maintains Full-Year Outlook

robot
Abstract generation in progress

CVS Health reported a strong Q4 2025 performance, with revenue growing 8% year-over-year to $105.7 billion and adjusted EPS exceeding forecasts, despite a decline in gross margin. The company saw significant growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments. While profitability faced challenges, diluted EPS rose due to a tax benefit, and analysts maintain a positive outlook for CVS stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)